About this journal
Aims and scope
Clinical Pharmacology: Advances and Applications is an international, peer-reviewed, open access, online journal, that focuses on the publication of clinical trials with a special interest in early clinical trials and the pharmacologic behavior of drugs and agents. The journal is dedicated to publishing rapidly all scientifically sound clinical trials whatever the outcome and it is therefore essential that they also report the detailed pharmacologic information/data. The journal aims at publishing articles that will allow predictions to be made from drug chemistry and pharmacology for eventual benefits and side effects. The journal provides the best available evidence to support decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by patients. The journal considers original research, methodology papers, short reports, reviews and commentaries in all areas of drug experience in humans.
Clinical Pharmacology: Advances and Applications will no longer consider meta-analyses for publication.
Journal metrics
Usage
- 33K annual downloads/views
Citation metrics
- 3.1 (2023) Impact Factor
- Q2 Impact Factor Best Quartile
- 2.6 (2023) 5 year IF
- 4.6 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 0.865 (2023) SNIP
- 0.695 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief
Arthur Frankel, Professor Chief of Hematology/Oncology, West Palm Beach VA Medical Center, USA
Associate Editor-in-Chief
Narasimha Murthy, Professor Pharmaceutics, University of Mississippi, USA
Editorial Board
William C. Cho, Professor Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
James Cook, Professor Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, USA
Esam Dajani, Professor Medicine, Loyola University-Chicago, USA
M.Elizabeth Fini, Professor Tufts University School of Medicine, USA
Marianna Foldvari, Professor Department of Pharmacy, University of Waterloo, Canada
Hendrik Fuchs, Professor for Target Cell Directed Tumor Therapy, Head of the Laboratory of Molecular Tumor Therapy and Deputy Director of the Department of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité - Universitätsmedizin Berlin, Germany
Ramesh Ganju, Professor Ohio State University, USA
Paul Kaufman, Professor Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Robert Kreitman, Professor Laboratory of Molecular Biology, National Cancer Institute, USA
Edythe London, Professor David Geffen School of Medicine, UCLA, Los Angeles, USA
William G. North, Professor Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, USA
Hui-Lin Pan, Professor Department of Anesthesiology and Perioperative Medicine, United States, The University of Texas MD Anderson Cancer Center, USA
Gaurav P. Patel, Associate Professor of Anesthesiology, MD, FASA, Department of Anesthesiology, Emory University School of Medicine, USA
Bruce Pollock, Professor Psychiatry, Pharmacology, University of Toronto, Canada
Eva Redei, Professor Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, USA
Scot Remick, Professor Maine Medical Center Cancer Institute; Tufts University School of Medicine, Boston MA, USA
Mandip Sachdeva, Professor College of Pharmacy and Pharmaceutical Sciences., Florida A&M University, USA
Stephen Safe, Professor Department of Veterinary Physiology and Pharmacology, Texas A&M University, USA
Daniel Vallera, Professor Department of Radiation Oncology, University of Minnesota, USA
Donna Wang, Professor Medicine, Michigan State University, USA
Abstracting and indexing
Clinical Pharmacology: Advances and Applications is indexed/tracked/covered by the following services:
Directory of Open Access Journals (DOAJ)
EMBASE (Elsevier)
Pubmed (NLM)
PubMed Central Selective Deposit Medicine & Health (NLM)
Scopus (Elsevier)
Open access
Clinical Pharmacology: Advances and Applications is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
Continuous
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors